Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Corticosteroid avoidance in pediatric renal transplantation.

Jayakumar R Vidhun1, Minnie M Sarwal

  • 1Department of Pediatrics, Stanford University, 300 Pasteur Drive, Palo Alto, CA 94305, USA.

Pediatric Nephrology (Berlin, Germany)
|February 4, 2005
PubMed
Summary

Minimizing corticosteroids in kidney transplants reduces side effects like bone and heart problems. Complete avoidance, using new drugs, shows promise for better growth and fewer complications in pediatric renal transplant patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not all reference samples are equal in single-cell transcriptomics of human kidney tissue.

JCI insight·2026
Same author

HLA and non-HLA antibody profiling in the urine of kidney transplant recipients.

Expert review of proteomics·2025
Same author

Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human Kidney.

bioRxiv : the preprint server for biology·2025
Same author

Leukocyte immunoglobulin like receptor B3 (LILRB3) and allograft survival: can precision medicine target health disparities?

Kidney international·2025
Same author

Novel mechanism for tubular injury in nephropathic cystinosis.

eLife·2025
Same author

Cytotoxic KLRG1+ IL-7R- effector CD8+ T cells distinguish kidney transplant recipients controlling cytomegalovirus reactivation.

Frontiers in immunology·2025

Area of Science:

  • Nephrology
  • Immunosuppression
  • Transplantation

Background:

  • Corticosteroids are crucial for renal replacement therapy in end-stage kidney disease.
  • However, their use causes significant dose-dependent morbidity, including bone, cardiovascular, and metabolic issues, plus growth retardation in children.

Purpose of the Study:

  • To evaluate strategies for minimizing corticosteroid use in renal transplantation.
  • To assess the impact of steroid minimization, alternate-day dosing, withdrawal, and avoidance on patient outcomes and side effects.

Main Methods:

  • Review of strategies including dose reduction, alternate-day regimens, steroid withdrawal, and complete avoidance.
  • Analysis of associated acute rejection rates, patient morbidity, and growth outcomes.

Related Experiment Videos

Main Results:

  • Steroid dose minimization increases acute rejection rates, though newer immunosuppressants mitigate this.
  • Complete corticosteroid avoidance in pediatric renal transplant patients is linked to 8-23% acute rejection, but shows significant catch-up growth and improved hypertension/hyperlipidemia.
  • Alternate-day therapy may improve growth but faces adherence challenges.

Conclusions:

  • Complete corticosteroid avoidance, enabled by novel induction and immunosuppressive agents, offers significant advantages in preventing steroid-related morbidity.
  • This approach may be applicable to other solid organ transplantations across all age groups.
  • Further research into steroid-free protocols is warranted to optimize transplant outcomes.